See also this year's filing and all EDGAR filings for this company.
PDF Report 0001739426_2021_RVL_Pharmaceuticals_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001739426, RVL Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 173,154,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 166,613,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 31,182,000 |
| 4 | LiabilitiesCurrent | 55,784,000 |
| 5 | LiabilitiesNoncurrent | 220,961,000 |
| 6 | remainder_Liabilities | 348,000 |
| 7 | CostOfGoodsAndServicesSold | 74,480,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 81,961,000 |
| 9 | ResearchAndDevelopmentExpense | 19,696,000 |
| 10 | remainder_Expenses | 67,486,000 |
| 11 | remainder_Revenues | 177,884,000 |
| 12 | remainder_NetIncome | -13,850,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 370,949,000 |
| 1 | Liabilities | 277,093,000 |
| 2 | Expenses | 243,623,000 |
| 3 | Revenues | 177,884,000 |
| 4 | StockholdersEquity | 93,856,000 |
| 5 | NetIncome | -79,589,000 |
| 6 | ComprehensiveNetIncome | -79,589,000 |
| 7 | BaseVar | 541,699,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.386 |
| 9 | EconomicCapitalRatio | 1.78 |